Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript March 31, 2025Rani Therapeutics Holdings, Inc. misses on earnings expectations.
Rani Therapeutics Holdings Inc. (RANI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 111,300 | $140,238 | -43% | 0% | |
| 2. | Avenue Capital Marc Lasry | 62,887 | $79,238 | 0.36% | |
| 3. | 21,300 | $26,838 | +546% | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.67 | 17,960 | $29,993.20 | 17,960 | 2024-12-13 | Filing | |
| $1.94 | 10,296 | $19,974.24 | 494,751 | 2024-12-09 | Filing | |
| $2.01 | 5,265,165 | $10,582,981.65 | 12,131,554 | 2023-11-24 | Filing | |
| $2.27 | 10,000 | $22,700.00 | 484,455 | 2023-12-06 | Filing | |
| $2.57 | 5,000 | $12,850.00 | 474,455 | 2023-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.26 | 523,738 | $1,705,395.68 | 8,302,194 | 2024-10-15 | Filing | |
| $2.55 | 3,305,622 | $8,436,277.91 | 8,825,932 | 2024-10-15 | Filing | |
| $2.01 | 5,265,165 | $10,582,981.65 | 8,400 | 2023-11-24 | Filing | |
| $11.62 | 9,210 | $107,020.20 | 66,445 | 2022-08-17 | Filing | |
| $10.51 | 71,042 | $746,651.42 | 75,655 | 2022-08-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 799,679 | $411,035 | 0% | |
| 2. | 203,190 | $104,419 | 0.53% | |
| 3. | 190,557 | $97,944 | 0% | |
| 4. | 156,140 | $80,240 | 0% | |
| 5. | 118,652 | $60,975 | 0% |
News See All
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.33.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to Rani Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode.
8 Best Stocks to Buy According to Billionaire Marc Lasry
In this article, we will take a look at the 8 Best Stocks to Buy According to Billionaire Marc Lasry.